Wyden Says Medicare Price Negotiation Plan Has Legs; Critics Doubtful

Drug Industry Daily
KEYWORDS HHS / Medicare
A A

Sen. Ron Wyden (D-Ore.) claims his proposal calling for the government to directly negotiate Medicare drug prices with manufacturers has amassed enough votes to pass the Senate, but congressional sources are skeptical that anything has changed since the bill was narrowly defeated in March.

To View This Article:

Login

Subscribe To Drug Industry Daily